Advertisement
Original article| Volume 40, ISSUE 4, P271-278, August 15, 1996

Download started.

Ok

Platelet serotonergic markers and tridimensional personality questionnaire measures in a clinical sample

      This paper is only available as a PDF. To read, Please Download here.
      A group of patients with major depressive disorder, with and without comorbid obsessive—compulsive disorder, completed the Tridimensional Personality Questionnaire (TPQ). Harm Avoidance scores were found to be high compared to published age-matched norms and to display a significant positive correlation with Hamilton Depression Rating Scale scores. Platelet 125I-lysergic acid diethylamide (125I-LSD) and 3H-paroxetine binding Bmax values were measured to test Cloninger's hypothesis that Harm Avoidance scores would correlate significantly with measures of serotonergic function. A significant inverse correlation was found between Harm Avoidance scores and 125I-LSD Bmax values. Correlations between 3H-paroxetine Bmax values and TPQ scale scores were not significant. These results suggest an alternative view of the literature relating platelet 5-hydroxytryptamine-2a receptors and mood disorders in that the temperament dimension, Harm Avoidance, may explain prior inconsistencies involving links with depression and suicidality.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders.
        3rd ed rev. American Psychiatric Press, New Delhi1987
        • Andres A
        • Rao M
        • Ostrowitzki S
        • Entzian W
        Human brain cortex and platelet serotonin2 receptor binding properties and their regulation by endogenous serotonin.
        Life Sci. 1992; 52: 313-321
        • Arora RC
        • Meltzer HY
        Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects.
        Am J Psychiatry. 1989; 146: 730-736
        • Arora RC
        • Meltzer HY
        Laterality and 3H-imipramine binding: Studies in the frontal cortex of normal controls and suicide victims.
        Biol Psychiatry. 1991; 29: 1016-1022
        • Arrango V
        • Emsberger P
        • Marzuk P
        • Chen J
        • Tierney H
        • Stanley M
        • Reis D
        • Mann J
        Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims.
        Arch Gen Psychiatry. 1990; 47: 1038-1047
        • Bastani B
        • Arora R
        • Meltzer H
        Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive disorder patients.
        Biol Psychiatry. 1991; 30: 131-139
        • Biegon A
        • Weizman A
        • Karp L
        • Ram A
        • Tiano S
        • Wolff M
        Serotonin 5-HT2 receptor binding on blood platelets—A peripheral marker for depression?.
        Life Sci. 1987; 41: 2485-2492
        • Biegon A
        • Grinspoon A
        • Blumenfeld B
        • Bleich A
        • Apter A
        • Mester R
        Increased serotonin 5-HT2 receptor binding on blood platelets of suicidal men.
        Psychopharmacology. 1990; 100: 165-167
        • Black D
        • Kelly M
        • Myers C
        • Noyes R
        Tritiated imipramine binding in obsessive-compulsive volunteers and psychiatrically normal controls.
        Biol Psychiatry. 1990; 27: 319-327
        • Brent DA
        • Zelenak JP
        • Bukstein O
        • Brown RV
        Reliability and validity of the structured interview for personality disorders in adolescents.
        J Am Acad Child Adolesc Psychiatry. 1990; 29: 349-354
        • Brown SL
        • Svrakic DM
        • Przybeck TR
        • Cloninger CR
        The relationship of personality to mood and anxiety states: A dimensional approach.
        J Psychiatr Res. 1992; 26: 197-211
        • Cloninger CR
        A systematic method for clinical description and classification of personality variants.
        Arch Gen Psychiatry. 1987; 44: 573-588
        • Cloninger CR
        Temperament and personality.
        Curr Opin Neurobiol. 1994; 4: 266-273
        • Cloninger CR
        • Przybeck TR
        • Svrakic DM
        The Tridimensional Personality Questionnaire: U.S. normative data.
        Psychol Rep. 1991; 69: 1047-1057
        • Cloninger CR
        • Przybeck TR
        • Svrakic DM
        • Wetzel RD
        The Temperament and Character Inventory (TCI): A Guide to Its Development and Use.
        Center for Psychobiology of Personality, Washington University, Washington, DC1994
        • Coccaro E
        • Siever L
        • Kanof P
        • Tsuboyama G
        • Davis K
        Intercorrelations between markers of central 5-HT function in man.
        in: Presented at the 43rd Annual Meeting of the Society of Biological Psychiatry, Montreal, Canada, May 19881988
        • Cook E
        • Fletcher K
        • Wainwright M
        • Marks N
        • Yan S
        • Leventhal B
        Primary structure of the human platelet serotonin 5-HT2a receptor: Identity with frontal cortex serotonin 5-HT2a receptor.
        J Neurochem. 1994; 63: 465-469
        • Cowen P
        • Charig E
        • Fraser S
        • Elliott J
        Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment.
        J Affective Disord. 1987; 13: 45-50
        • D'haenen H
        • De Waele M
        • Leysen J
        Platelet 3H-paroxetine binding in depressed patients.
        Psychiatry Res. 1988; 26: 11-17
        • D'Hondt P
        • Maes M
        • Leysen J
        • Gommeren W
        • Scharpe S
        • Cosyns P
        Binding of 3H-paroxetine to platelets of depressed patients: Seasonal differences and effects of diagnostic classification.
        J Affective Disord. 1994; 32: 27-35
        • Egrise D
        • Desmedt D
        • Schoutens A
        • Mendlewicz J
        Circannual variation in the density of tritiated imipramine binding sites on blood platelets in man.
        Neuropsychobiology. 1983; 10: 101-102
        • Ellis P
        • Salmond C
        Is platelet imipramine binding reduced in depression? A meta-analysis.
        Biol Psychiatry. 1994; 36: 292-299
        • Galzin A
        • Poirier M
        • Loo H
        • Sechter D
        • Zarifian E
        • Langer S
        3H-paroxetine binding from healthy volunteers and depressed patients.
        Br J Pharmacol. 1988; 93: 12P
        • Goodman W
        • Price L
        • Rasmussen S
        • Masure C
        • Fleishmann C
        • Hill C
        • Heninger G
        • Charney D
        The Yale-Brown Obsessive Compulsive Sale (Y-BOCS): II. validity.
        Arch Gen Psychiatry. 1989; 46: 1012-1016
        • Gross-Isseroff R
        • Salama D
        • Israeli M
        • Biegon A
        Autoradiographic analysis of [3H]ketanserin binding in the human brain post mortem: Effect of suicide.
        Brain Res. 1990; 507: 208-215
        • Hamilton M
        A rating scale for depression.
        J Neurol Neurosurg Psychiatry. 1960; 23: 56-62
        • Heath AC
        • Cloninger CR
        • Martin NG
        Testing a model for the genetic structure of personality: A comparison of the Personality Systems of Cloninger and Eysenck.
        J Per Soc Psychology. 1994; 66: 762-775
        • Hrdina P
        • Demeter E
        • Vu T
        • Sotonyi P
        • Palkovits M
        5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: Increase in 5-HT2 sites in cortex and amygdala.
        Brain Res. 1993; 614: 37-44
        • Insel T
        • Mueller E
        • Alterman I
        • Linnoila M
        • Murphy D
        Obsessive-compulsive disorder and serotonin: Is there a connection?.
        Biol Psychiatry. 1985; 20: 1174-1188
        • Iny J
        • Pecknold J
        • Suranyi-Cadotte B
        • Bernier B
        • Luthe L
        • Nair N
        • Meaney M
        Studies of a neurochemical link between depression, anxiety, and stress from 3H-imipramine and 3H-paroxetine binding on human platelet.
        Biol Psychiatry. 1994; 36: 281-291
        • Joffe RT
        • Bagby RM
        • Levitt AJ
        • Regan JJ
        • Parker JD
        The Tridimensional Personality Questionnaire in major depression.
        Am J Psychiatry. 1993; 150: 959-960
      1. (St. Louis, MO)
        • Joyce P
        • Mulder R
        • Sellman J
        • Oakey-Brown M
        • Wilson D
        • Sullivan A
        • Casey J
        • Cloninger R
        Endocrine responses to fenfluramine in depression: Relationships with gender, depressive symptoms and temperament.
        in: Cloninger CR The Temperament and Character Inventory (TCI): A Guide to Its Development and Use. Center for Psychobiology of Personality, St. Louis, MO1994: 82
        • Joyce PR
        • Mulder RT
        • Cloninger CR
        Temperament predicts clomipramine and desipramine response in major depression.
        J Affective Disord. 1994; 30: 35-46
        • Kim S
        • Dysken M
        • Pandey G
        • Davis J
        Platelet 3H-imipramine binding sites in obsessive-compulsive behavior.
        Biol Psychiatry. 1991; 30: 467-474
        • Klompenhouwer J-L
        • Fekkes D
        • van Hulst A
        • Moleman P
        • Pepplinkhuizen L
        • Mulder P
        Seasonal variations in binding of 3H-paroxetine to blood platelets in healthy volunteers: Indications for a gender difference.
        Biol Psychiatry. 1990; 28: 509-517
        • Lawrence K
        • Falkowski J
        • Jacobson R
        • Horton R
        Platelet uptake sites in depression—3 concurrent measurements using 3H-imipramine and 3H-paroxetine.
        Psychopharmacology. 1993; 110: 235-239
        • Lesch K
        • Wolozin B
        • Murphy D
        • Riederer P
        Primary structure of the human platelet serotonin uptake site: Identity with the brain serotonin transporter.
        J Neurochem. 1993; 60: 2319-2322
        • Limson R
        • Goldman D
        • Roy A
        • Lamparski D
        • Ravitz B
        • Adinoff B
        • Linnoila M
        Personality and cerebrospinal fluid monoamine metabolites in alcoholics and controls.
        Arch Gen Psychiatry. 1991; 48: 437-441
        • Mann J
        • Stanley M
        • McBride A
        • McEwen B
        Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims.
        Arch Gen Psychiatry. 1986; 43: 954-959
        • Mann J
        • McBride A
        • Brown R
        • Linnoila M
        • Leon A
        • DeMeo M
        • Mieczkowski M
        • Myers J
        • Stanley M
        Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients.
        Arch Gen Psychiatry. 1992; 49: 442-446
        • Marazziti D
        • Hollander E
        • Lensi P
        • Ravagli S
        • Cassano G
        Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder.
        Psychiatry Res. 1992; 42: 41-51
        • Martensson B
        • Wagner A
        • Beck O
        • Brodin K
        • Montero D
        • Asberg M
        Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3H-imipramine binding and serotonin uptake and concentration in major depressive disorder.
        Acta Psychiatr Scand. 1991; 83: 125-133
      2. ([abstract])
        • McBride P
        • Brown R
        • De Meo M
        • Keilp J
        • Stanley M
        • Mann J
        • Polly M
        Platelet 5-HT2 receptors: Depression and suicide.
        (New Research, NR157) American Psychiatric Association, Washington University1987
        • McBride P
        • Brown R
        • De Meo M
        • Keilp J
        • Mieczkowski T
        • Mann J
        The relationship of platelet 5-HT2 receptor indices to major depressive disorder, personality traits, and suicidal behavior.
        Biol Psychiatry. 1994; 35: 295-308
        • McKeith I
        • Marshall E
        • Ferrier I
        • Armstrong M
        • Kennedy W
        • Perry R
        • Perry E
        • Eccleston D
        5-HT receptor binding in post-mortem brain from patients with affective disorder.
        J Affective Disord. 1987; 13: 67-74
        • Mellerup E
        • Plenge P
        Imipramine binding in depression and other psychiatric conditions.
        Acta Psychiatr Scand. 1988; 78: 61-68
        • Mellerup E
        • Plenge P
        Why some depressed patients may have low platelet 3H-imipramine binding.
        Acta Psychiatr Scand. 1990; 82: 330-334
        • Mellerup E
        • Dam H
        • Lauritzen L
        • Plenge P
        Platelet 3H-imipramine and 3H-paroxetine binding during treatment with psychoactive drugs.
        Biol Psychiatry. 1991; 30: 1056-1058
        • Moret C
        • Briley M
        Platelet 3H-paroxetine binding to the serotonin transporter is insensitive to changes in central serotonergic innervation in the rat.
        Psychiatry Res. 1991; 38: 97-104
        • Nagoshi C
        • Walter D
        • Muntaner C
        • Haertzen C
        Validation of the Tridimensional Personality Questionnaire in a sample of male drug users.
        Per Indiv Diff. 1992; 13: 401-409
      3. Nelson E (in press): An open label study of nefazodone in the treatment of depression with and without comorbid obsessive compulsive disorder. Annals Clin Psychiatry.

      4. Nelson E, Sheline Y, Bardgett M, Jackson J, Csernansky J (in press): Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive compulsive disorder. Psychiatry Res.

      5. Nelson E, Sheline Y, Bardgett M, Jackson J, Csernansky J (in submission): Platelet serotonin-2 receptor binding in major depressive disorder with and without comorbid obsessive compulsive disorder.

        • Nemeroff C
        • Knight D
        • Franks J
        • Craighead W
        • Krishnan K
        Further studies on platelet serotonin transporter binding in depression.
        Am J Psychiatry. 1994; 151: 1623-1625
        • Ostrowitzki S
        • Rao ML
        • Redei J
        • Andres AH
        Concurrence of cortex and platelet serotonin2 receptor binding characteristics in the individual and the putative regulation by serotonin.
        J Neural Transm. 1993; 93: 27-35
        • Owen F
        • Cross A
        • Crow T
        • Deakin J
        • Ferrier I
        • Lofthouse R
        • Poulter M
        Brain 5-HT2 receptors and suicide.
        Lancet. 1983; ii: 1256
        • Pandey GN
        • Pandey SC
        • Janicak P
        • Marks R
        • Davis J
        Platelet serotonin-2 receptor binding sites in depression and suicide.
        Biol Psychiatry. 1990; 28: 215-222
        • Pandey SC
        • Kim SW
        • Davis J
        • Pandey GN
        Platelet serotonin-2 receptors in obsessive compulsive disorder.
        Biol Psychiatry. 1993; 33: 367-372
        • Pfohl B
        • Black DW
        • Noyes R
        • Kelley M
        • Blum N
        A test of the tridimensional personality theory: Association with diagnosis and platelet imipramine binding in obsessivecompulsive disorder.
        Biol Psychiatry. 1990; 28: 41-46
        • Pletscher A
        The 5-hydroxytryptamine system of blood platelets.
        in: Physiology and pathophysiology. lnt J Cardiol. 14. 1987: 177-188
        • Sheline Y
        • Newcomer J
        • Bardgett M
        • Csernansky J
        Platelet serotonin markers and depressive symptomatology.
        Biol Psychiatry. 1995; 37: 442-447
        • Simonsson P
        • Berglund M
        • Oreland L
        • Moberg A-L
        • Alling C
        Serotonin-stimulated phosphoinositide hydrolysis in platelets from post-withdrawal alcoholics.
        Alcohol. 1992; 27: 607-612
        • Spitzer R
        • Williams J
        • Gibbon M
        • First M
        Structured Clinical Interview for DSM-III-R—Patient Edition (SCID-P, 9/1/89 Version).
        Biometrics Research Department, Chicago1989
        • Stanley M
        • Mann J
        Increased serotonin-2 binding sites in frontal cortex of suicide victims.
        Lancet. 1983; i: 214-216
        • Stoff D
        • Goldman W
        • Bridger W
        • Jain A
        • Pylypiw A
        No correlation between platelet imipramine binding and CSF 5-HIAA in neurosurgical patients.
        Psychiatry Res. 1990; 33: 323-326
        • Svrakic DM
        • Przybeck TR
        • Cloninger CR
        Mood states and personality traits.
        J Affective Disord. 1992; 24: 217-226
        • Svrakic DM
        • Whitehead C
        • Przybeck TR
        • Cloninger CR
        Different diagnosis of personality disorders by the seven factor model of temperament and character.
        Arch Gen Psychiatry. 1993; 50: 991-999
      6. Tancer M, Ranc J, Golden R (in submission): The Tridimensional Personality Questionnaire in patients with social phobia and healthy volunteers: Correlations with pharmacological challenge tests.

        • Vitiello B
        • Shimon H
        • Behar D
        • Stoff D
        • Bridger W
        • Friedman E
        Platelet imipramine binding and serotonin uptake in obsessive-compulsive patients.
        Acta Psychiatr Scand. 1991; 84: 29-32
        • Wagner A
        • Aberg-Wistedt A
        • Asberg M
        • Bertilsson L
        • Martensson B
        • Montero D
        Effects of antidepressant treatments on platelet tritiated imipramine binding in major depressive disorder.
        Arch Gen Psychiatry. 1987; 44: 870-877
        • Waller D
        • Gullion C
        • Petty F
        • Hardy B
        • Murdock M
        • Rush A
        Tridimensional Personality Questionnaire and serotonin in bulimia nervosa.
        Psychiatry Res. 1993; 48: 9-15
        • Weizman A
        • Carmi M
        • Hermesh H
        • Shahar A
        • Apter A
        • Tyano S
        • Rehavi M
        High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients.
        Am J Psychiatry. 1986; 143: 335-339
        • Weizman A
        • Mandel A
        • Barber Y
        • Weitz R
        • Cohen A
        • Mester R
        • Rehavi M
        Decreased platelet imipramine binding in Tourette syndrome children with obsessive-compulsive disorder.
        Biol Psychiatry. 1992; 31: 705-711
        • Whitaker P
        • Warsh J
        • Stancer H
        • Prasad E
        • Vint C
        Seasonal variation in platelet 3H-imipramine binding: Comparable values in control and depressed populations.
        Psychiatry Res. 1984; 11: 127-131